• 2005

Company Description

AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.

AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2005
  • Founders:

    Robert E. Desjardins
  • Company Website:

  • Company E-mail:

  • Company Address:

    Mack Centre IV, 4th Floor
    Paramus, NJ
    United States
  • CEO:

    • Robert E. Desjardins
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits